Evidence map›Paper›PMID 22742831›Full record

ArticleCNS neuroscience & therapeutics2012

Chronic h1-antihistamine treatment increases seizure susceptibility after withdrawal by impairing glutamine synthetase.

Wei-Wei Hu, Qi Fang, Zheng-Hao Xu, Hai-Jing Yan, Ping He, Kai Zhong, Yan-Ying Fan, Ying Yang, Xiang-Nan Zhang, Chun-Yang Zhang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Region-independent active CNS net uptake of marketed HFrontiers in cellular neuroscience · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Wei-Wei HuDepartment of Pharmacology, Key Laboratory of Medical Neurobiology of Ministry of Health of China, Zhejiang Province Key Laboratory of Neurobiology, School of Basic Medical Sciences, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Qi Fang
Zheng-Hao Xu
Hai-Jing Yan
Ping He
Kai Zhong
Yan-Ying Fan
Ying Yang
Xiang-Nan Zhang
Chun-Yang Zhang
Hiroshi Ohtsu
Tian-Le Xu
Zhong Chen
Zhejiang University · CNShanghai Jiao Tong University · CNTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the effect of chronic H1-antihistamine treatment on seizure susceptibility after drug withdrawal in nonepileptic rats and to further study its relation to glutamine synthetase (GS), which is the key enzyme for glutamate metabolism and gamma aminobutyric acid (GABA) synthesis.

methodsAfter drug withdrawal from a 2-week treatment with diphenhydramine or pyrilamine, seizure susceptibility was determined by amygdaloid kindling or pentylenetetrazol model; meanwhile, the GS expression or activity was analyzed. The glutamine, glutamate, and GABA contents were measured by high-performance liquid chromatography.

resultsSeizure susceptibility significantly increased in amygdaloid kindling and pentylenetetrazol model 10 days after drug withdrawal from a 2-week treatment with H1-antihistamines. Meanwhile, GS activity and expression in the cortex or hippocampus decreased simultaneously with a marked decline of glutamine and GABA content. Comparable inhibition of GS activity by methionine sulfoximine was also sufficient to increase the susceptibility, while supplementation with glutamine reversed the high susceptibility 10 days after diphenhydramine withdrawal. Moreover, the seizure susceptibility increased 10 days after diphenhydramine withdrawal in wild-type mice but not in histidine decarboxylase knockout mice, which lack histamine.

conclusionsChronic H1-antihistamine treatment produces long-lasting increase in seizure susceptibility in nonepileptic rodents after drug withdrawal and its mechanism involves impairment of GS through blocking the action of histamine.

Indexed as

AnimalsAstrocytesBlotting, WesternChromatography, High Pressure LiquidConvulsantsElectroshockgamma-Aminobutyric AcidGlutamate-Ammonia LigaseGlutamic AcidGlutamineHistamine H1 AntagonistsHistidine DecarboxylaseImmunohistochemistryKindling, NeurologicMaleMethionine SulfoximineConvulsantsgamma-Aminobutyric AcidGlutamate-Ammonia LigaseGlutamic AcidGlutamineHistamine H1 AntagonistsHistidine DecarboxylaseMethionine SulfoximinePentylenetetrazole

Identifiers

PMID22742831
PMCPMC6493495
OpenAlexW2031303282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.